Latest updates for Spyi

Fresh curated links around SPYI are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • FYEE: Buy-Write ETF With 7.7% Yield And Superior Risk-Adjusted Return
  • SPYD vs. SPYG – Which ETF Is Better For You? A 2026 Comparison
  • RSPA: A 9% Yield For Investors Wary Of The AI-Led Market

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

FYEE: Buy-Write ETF With 7.7% Yield And Superior Risk-Adjusted Return

Read source
radicalfire.com /2 weeks ago

SPYD vs. SPYG – Which ETF Is Better For You? A 2026 Comparison

In a SPYD vs. SPYG comparison, are you wondering which ETF would do wonders to your investment portfolio? Learn more about their key features, composition, and performance, and ass...

Read source
seekingalpha.com /1 month ago

RSPA: A 9% Yield For Investors Wary Of The AI-Led Market

Read source
seekingalpha.com /1 month ago

World Markets Watchlist: June 15, 2026

Read source
seekingalpha.com /3 days ago

SEI: Buy Before The S&P 600 Flows Arrive

Read source
seekingalpha.com /3 weeks ago

World Markets Watchlist: June 22, 2026

Read source
fool.com /1 week ago

Which S&P 500 ETF Is Better in 2026? State Street's SPY or iShares' IVV?

IVV's 0.03% expense ratio and $886 billion in assets make it a compelling alternative for buy-and-hold investors seeking broad market exposure.

Read source
seekingalpha.com /1 week ago

SPMO: The Leaner Way To Own The S&P 500

Read source
fool.com /1 month ago

This S&P 500 Income ETF Returned 28% in a Year. One Fund Added $18 Million More

The Goldman Sachs S&P 500 Premium Income ETF targets steady income and equity exposure through an options-based strategy for U.S. investors.

Read source
seekingalpha.com /2 weeks ago

Spyre Therapeutics: Deep And Diverse Immunology Pipeline Awaiting Data

Read source
seekingalpha.com /2 weeks ago

A Month For 'The Rest'

Read source
seekingalpha.com /2 weeks ago

Interesting Chart Updates

Read source
fiercebiotech.com /1 month ago

Spyre spies another edge for UC ambitions with midstage win for anti-TL1A antibody

The company's SPY002 prompted a 10.7-point reduction from baseline levels in patients’ Robart’s Histopathology Index (RHI) scores by week 12.

Read source
seekingalpha.com /1 week ago

The 1-Minute Market Report, July 4, 2026

Read source
seekingalpha.com /1 month ago

GPIX: Retirees Don't Need The 4% Rule With This Monthly Income ETF

Read source
seekingalpha.com /2 weeks ago

Wall Street Week Ahead

Read source
seekingalpha.com /4 days ago

The 1-Minute Market Report, July 11, 2026

Read source
seekingalpha.com /2 weeks ago

ADX Vs. ASG: Liberty Growth Vs. Adams Diversified

Read source
seekingalpha.com /18 hours ago

HFSI: Continues To Do What It Is Supposed To

Read source
seekingalpha.com /1 month ago

StyleBox Update: The One Surprise Is Small Cap Growth And Value Starting To Roll

Read source
seekingalpha.com /1 month ago

Business Conditions Monthly March 2026

Read source
seekingalpha.com /15 hours ago

XSMO: A Cleaner Way To Own Small Caps

Read source
seekingalpha.com /3 weeks ago

Argosy Property Limited (IGPYF) Shareholder/Analyst Call - Slideshow

Read source
seekingalpha.com /1 month ago

SPMO: Momentum Faces Pressure, But AI-Fueled Growth Still Makes It A Buy

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Spyi

seekingalpha.com

Recent coverage from public sources
Public source

radicalfire.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source